Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Net Income towards Common Stockholders: 2017-2020

Historic Net Income towards Common Stockholders for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$82.1 million.

  • Cogent Biosciences' Net Income towards Common Stockholders fell 595.65% to -$11.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.1 million, marking a year-over-year decrease of 157.77%. This contributed to the annual value of -$82.1 million for FY2020, which is 157.77% down from last year.
  • As of FY2020, Cogent Biosciences' Net Income towards Common Stockholders stood at -$82.1 million, which was down 157.77% from -$31.8 million recorded in FY2019.
  • In the past 5 years, Cogent Biosciences' Net Income towards Common Stockholders registered a high of -$25.6 million during FY2017, and its lowest value of -$82.1 million during FY2020.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$34.5 million (2018), whereas its average is -$49.5 million.
  • In the last 5 years, Cogent Biosciences' Net Income towards Common Stockholders grew by 7.86% in 2019 and then tumbled by 157.77% in 2020.
  • Over the past 4 years, Cogent Biosciences' Net Income towards Common Stockholders (Yearly) stood at -$25.6 million in 2017, then crashed by 35.18% to -$34.5 million in 2018, then rose by 7.86% to -$31.8 million in 2019, then tumbled by 157.77% to -$82.1 million in 2020.